PURE — Pure Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00- $5.91m
- $10.81m
- $2.20m
- 25
- 30
- 13
- 10
Annual cashflow statement for Pure Biosciences, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2021 July 31st | 2022 July 31st | 2023 July 31st | 2024 July 31st | 2025 July 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.32 | -3.49 | -3.96 | -3.35 | -2.4 |
| Depreciation | |||||
| Non-Cash Items | 0.991 | 0.757 | 0.673 | 0.274 | 0.147 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.011 | 0.103 | -0.107 | 0.397 | 0.235 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.17 | -2.42 | -3.28 | -2.53 | -2.02 |
| Capital Expenditures | -0.521 | -0.081 | -0.033 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.521 | -0.081 | -0.033 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.239 | 3.5 | 1.01 | 1.78 | 2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.45 | 1 | -2.3 | -0.746 | -0.015 |